Healthcare IT News March 24, 2025
Anthony Vecchione

Following the announcement, California Attorney General Rob Bonta issued an urgent consumer alert advising users to request the company to delete their genetic data.

Human genetics and biotechnology company 23andMe has filed for Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri to facilitate a sales process.

In a press release, the company said it intends to continue operating its business throughout the sales process and no changes will be made to the way the company will store, manage or protect customer data.

Anne Wojcicki is resigning from her role as CEO, and Joe Selsavage, chief financial and accounting officer, has been named interim CEO by the board. Wojcicki will continue to serve...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Pharma / Biotech, Precision Medicine
JPM 2026: Genoa Ventures’ Jenny Rooke on Next-Gen Clinical Assessment Tools
From Early Detection to Targeted Therapy: How AI is Reframing Precision Medicine
How Precision Medicine and AI are Evolving: An MD Anderson Perspective
Bringing Precision Medicine Into the Home
Inside the Virtual Cell: New Depths for Precision Medicine

Share Article